Mandrake Bio raises $1.9M pre seed
Announced 16 July 2026
◆ The Round
Mandrake Bio raised $1.9M in pre seed funding, announced on 16 July 2026, led by Activate, Antler India, with participation from Spectrum Impact, DeVC. The round is tracked live by Fusion42 as part of the Raise fund database and the Scout startup database.
◆ About Mandrake Bio
Bengaluru-based biotechnology startup using artificial intelligence to design new gene-editing enzymes for agriculture and healthcare. Mandrake Bio is based in India and currently at pre seed stage, operating in Biotech, Digital Health.
◆ Investors
LeadActivate, Antler India
ParticipationSpectrum Impact, DeVC
◆ Market context
This funding event is a citable node in Fusion42's market graph: it links Mandrake Bio's Scout profile to the funds behind the round and to related Wire analysis, and is refreshed from public announcements as the round is confirmed or extended. It is the same live market data Arthur reasons over when benchmarking a founder's own raise against what is closing in the market right now.
◆ Explore the market
◆ FAQ
How much did Mandrake Bio raise?
Mandrake Bio raised $1.9M in its pre-seed round, announced 2026-07-16.
Who invested in Mandrake Bio's pre-seed round?
The round was led by Activate and Antler India, with participation from Spectrum Impact and DeVC.
What does Mandrake Bio do?
Bengaluru-based biotechnology startup using artificial intelligence to design new gene-editing enzymes for agriculture and healthcare.
Verified 16 July 2026 · Sources: public filings